Jeff Yass’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Sell
15,132
-160,955
-91% -$115K ﹤0.01% 13106
2026
Q1
$80.6K Sell
176,087
-623,370
-78% -$575K ﹤0.01% 12459
2025
Q4
$1.76M Buy
+799,457
New +$1.29M ﹤0.01% 5915
2025
Q3
Sell
-90,761
Closed -$147K 14112
2025
Q2
$147K Buy
90,761
+34,067
+60% +$55K ﹤0.01% 11513
2025
Q1
$67.5K Buy
56,694
+14,320
+34% +$22.9K ﹤0.01% 11756
2024
Q4
$87.3K Buy
+42,374
New +$98.7K ﹤0.01% 11426

Other funds holding GUTS

Jeff Yass's GUTS Position: Q2 2026 in Review

Jeff Yass reduced its Fractyl Health (GUTS) stake by 91% in Q2 2026, selling an estimated $115K and leaving 15,132 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #13106.

Jeff Yass first reported a position in GUTS in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.76M in Q4 2025. 76 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Jeff Yass held 15,132 shares of Fractyl Health worth $12K as of Q2 2026.
  • Jeff Yass sold 160,955 Fractyl Health shares in Q2 2026, an estimated $115K.
  • Fractyl Health made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13106 holding.
  • Jeff Yass first reported a position in Fractyl Health in Q4 2024 and has held it in 6 quarters since.
  • Jeff Yass's Fractyl Health position peaked at $1.76M in Q4 2025.
  • 76 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.